23 May 2013
Keywords: india, lupin, marketing, deal, suprax, indian, drugmaker
Article | 30 June 2008
Indian drugmaker Lupin's US subsidiary has entered into a promotion agreement for Suprax (cefixime) 400mg tablets with ASCEND Therapeutics.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
© 2013 thepharmaletter.com